EURAX HC is a brand name for Hydrocortisone. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Relief of inflammation and pruritus associated with: Irritant contact dermatitis Allergic contact dermatitis Insect bite reactions Mild to moderate eczema
Verbatim from this product's MHRA label. Tap a section to expand.
Adults Apply sparingly over a small area twice a day for a maximum period of 1 week. Occlusive dressings should not be used.
Paediatric population:
Eurax Hc Cream can be used in children over 10 years of age and applied as described for adults. Do not use in children under 10 years of age except under medical supervision.
Method of administration:
For cutaneous use.
Adverse reactions are listed below by frequency. Frequencies are defined as: uncommon (>1/1,000 to < 1/100), rare (> 1/10,000 to < 1/1,000) and very rare (<1/10,000).
Skin and subcutaneous tissue disorders:
Uncommon: pruritus Rare: contact dermatitis, hypersensitivity (including/like rash, eczema, erythema, skin irritation, angioedema) Treatment should be discontinued if severe irritation occurs. In case of longer lasting administration skin atrophy, telangiectasia, striae, steroid induced acne, peroral dermatitis and hypertrichosis cannot be excluded.
4) Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store.
Eurax Hc is indicated for external use only. Do not use in children under 10 years of age except under medical supervision. Occlusive dressings should not be used Eurax Hc should not be used in buccal mucosa or other mucous membranes or in or around the eyes since contact with the eyelids may give rise to conjunctival inflammation.
In case of accidental contact with the eyes, or mucosa rinse thoroughly with running water. Eurax Hc should not be applied in the presence of exudative wounds, broken skin, or very inflamed skin. g. contact dermatitis); propyl parahydroxybenzoate (E216) and methyl parahydroxybenzoate (E218) which may cause allergic reactions (possibly delayed).
Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.
Instruct patients not to smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build up but not totally remove it.
This medicine contains 200 mg propylene glycol(E1520) in each gram of cream. This medicine contains fragrance with benzyl alcohol, benzyl benzoate, citral, citronellol, coumarin, d-limonene, eugenol, geraniol and linalool which may cause allergic reactions.
Long term use of topical steroids can result in the development of rebound flares after stopping treatment (topical steroid withdrawal syndrome). A severe form of rebound flare can develop which takes the form of a dermatitis with intense redness, stinging and burning that can spread beyond the initial treatment area.
1, List of excipients). Bacterial, viral or fungal infections of the skin. Acute exudative dermatoses. Application to ulcerated areas.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Hydrocortisone in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
It is more likely to occur when delicate skin sites such as the face and flexures are treated. Should there be a reoccurrence of the condition within days to weeks after successful treatment a withdrawal reaction should be suspected.
Reapplication should be with caution and specialist advise is recommended in these cases or other treatment options should be considered. The label will state mild steroid.